细胞表面标誌物的全球市场 - 市场规模、份额、成长分析：按类型、按应用分类 - 产业预测（2023-2030）

Global Cell Surface Markers Market Size, Share, Growth Analysis, By Type(Flow cytometers, hematology anlayzers and reagents and kits), By Application(Disease diagnosis and identification and research/drug discovery) - Industry Forecast 2023-2030

出版日期: 2023年10月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2021年全球细胞表面标誌物市场规模为259.2亿美元，2022年为279.9亿美元。预计该市场在预测期（2023-2030年）将以8%的年复合成长率成长，到2030年达到518.1亿美元。

全球细胞表面标誌物市场是一个快速成长且充满活力的行业，在医学研究、诊断和药物开发等各个领域发挥重要作用。细胞表面标誌物，也称为细胞表面抗原或分化簇 (CD) 标记，是位于细胞外表面的蛋白质或分子，可作为识别特定细胞类型的标籤。这些标记物广泛用于识别、分离和表征不同的细胞群，有助于了解细胞功能、疾病机制和治疗标靶。该市场的推动因素包括慢性病的增加、个人化医疗需求的增加、流式细胞仪和其他细胞分析技术的进步以及研发活动投资的增加。此外，细胞表面标誌物在肿瘤学、免疫学、干细胞研究、感染疾病等领域的不断扩大应用也进一步推动了市场的成长。然而，先进细胞分析设备的高成本和细胞表面标誌物分析的复杂性等挑战限制了市场潜力。然而，持续的技术进步，例如多重、高通量分析平台的开发，有可能克服这些障碍并推动全球细胞表面标誌物市场的未来成长。

全球细胞表面标誌物市场的关键驱动因素之一是慢性病盛行率的上升。癌症、自体免疫疾病等慢性疾病的盛行率不断上升，推动了对细胞表面标誌物的需求。这些标记物在疾病诊断、预后和标靶治疗中发挥重要作用，有助于个人化医疗的方法。全球慢性病负担日益加重，推动了对先进细胞分析技术的需求，推动了整体市场的成长。

全球细胞表面标誌物市场的主要抑制因素是先进细胞分析设备和技术的高成本。与先进的流式细胞仪、血液分析仪和其他细胞分析平台相关的采购和维护成本可能很高。此外，用于细胞表面标誌物分析的试剂和试剂盒的成本是巨大的。高昂的进入和营运成本限制了先进细胞分析技术的取得和采用，特别是在资源有限的环境和新兴市场中。这对市场成长构成了挑战，特别是在医疗保健系统普及对成本敏感的地区。

该报告研究了全球细胞表面标誌物市场，并提供了市场概述，包括按类型、应用、区域和参与市场的公司概况分類的趋势。

主要企业简介
- Thermo Fisher Scientific
- QIAGEN NV
- Bio-Rad Laboratories
- F. Hoffman-La Roche
- BD
- Grifols SA
- GenScript
- Siemens Healthcare Private Limited
- Abcam plc.
- Merck KGaA
- Beckman Coulter, Inc.
- Agilent Technologies
- Sysmex Corporation
- Lonza Group Ltd.
- BioLegend, Inc.
- Novus Biologicals
- Miltenyi Biotec
- Cell Signaling Technology
- Sino Biological Inc.
- R&D Systems

简介目录

Product Code: SQMIG35J2063

Global Cell Surface Markers Market size was valued at USD 25.92 billion in 2021 and is poised to grow from USD 27.99 billion in 2022 to USD 51.81 billion by 2030, at a CAGR of 8% during the forecast period (2023-2030).

The global cell surface markers market is a rapidly growing and dynamic industry that plays a crucial role in various fields, including medical research, diagnostics, and drug development. Cell surface markers, also known as cell surface antigens or cluster of differentiation (CD) markers, are proteins or molecules present on the outer surface of cells, which serve as identification tags for specific cell types. These markers are extensively utilized in the identification, isolation, and characterization of different cell populations, aiding in the understanding of cell function, disease mechanisms, and therapeutic targeting. The market is driven by factors such as the increasing prevalence of chronic diseases, rising demand for personalized medicine, advancements in flow cytometry and other cell analysis techniques, and growing investments in research and development activities. Additionally, the expanding applications of cell surface markers in oncology, immunology, stem cell research, and infectious diseases further propel market growth. However, challenges such as the high cost of advanced cell analysis instruments and the complexity of cell surface marker analysis limit the market's full potential. Nevertheless, ongoing technological advancements, such as the development of multiplexed and high-throughput analysis platforms, hold promise for overcoming these barriers and driving the future growth of the global cell surface markers market.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Surface Markers Market Segmental Analysis

Global Cell Surface Markers Market is segmented on the basis of type, application, and region. Based on type, the market can be segmented into Flow cytometers, hematology anlayzers and reagents and kits. Based on application, the market is segmented into Disease diagnosis and identification and research/drug discovery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Cell Surface Markers Market Dynamics

Drivers for Global Cell Surface Markers Market

Increasing prevalence of chronic diseases

One key driver of the global cell surface markers market is the increasing prevalence of chronic diseases. The rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders, drives the demand for cell surface markers. These markers play a crucial role in disease diagnosis, prognosis, and targeted therapies, aiding in personalized medicine approaches. The growing burden of chronic diseases worldwide fuels the demand for advanced cell analysis techniques and drives the overall market growth.

Restraints in the Global Cell Surface Markers Market

High cost of advanced cell analysis instruments and techniques

A key restraint of the global cell surface markers market is the high cost of advanced cell analysis instruments and techniques. The acquisition and maintenance costs associated with sophisticated flow cytometers, hematology analyzers, and other cell analysis platforms can be significant. Additionally, the cost of reagents and kits used in cell surface marker analysis can also be substantial. The high cost of entry and operation limits the accessibility and adoption of advanced cell analysis technologies, especially in resource-constrained settings and emerging markets. This poses a challenge for market growth, particularly in regions where cost-sensitive healthcare systems prevail.

Market Trends of Global Cell Surface Markers Key

Increasing focus on personalized medicine

One key market trend in the global cell surface markers market is the increasing focus on personalized medicine. Personalized medicine aims to tailor medical treatments to individual patients based on their unique characteristics, including cell surface markers. Cell surface markers play a vital role in identifying specific cell populations and determining their response to therapies. The growing understanding of the role of cell surface markers in disease progression and treatment response has led to the development of targeted therapies that can be customized based on an individual's cell surface marker profile. This trend towards personalized medicine is driving the demand for advanced cell analysis techniques and innovative cell surface marker detection methods in the market.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Cell Surface Markers Market by Type
- Market Overview
- Flow cytometers
- hematology anlayzers and reagents and kits
Global Cell Surface Markers Market by Application
- Market Overview
- Disease diagnosis and identification and research/drug discovery
Global Cell Surface Markers Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Thermo Fisher Scientific (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- QIAGEN N.V. (Netherlands)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bio-Rad Laboratories (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- F. Hoffman-La Roche (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BD (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Grifols SA (Spain)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GenScript (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Siemens Healthcare Private Limited (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Abcam plc. (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck KGaA (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Beckman Coulter, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Agilent Technologies (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sysmex Corporation (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Lonza Group Ltd. (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioLegend, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novus Biologicals (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Miltenyi Biotec (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cell Signaling Technology (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sino Biological Inc. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- R&D Systems (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments